List Alan 4

What Happened

• Director List Alan was granted an award of 156,240 derivative securities (reported as an option grant) by TuHURA Biosciences (HURA) on February 12, 2026. The Form 4 reports the transaction as an award/acquisition (code A) with $0.00 listed in the price column, indicating no cash changed hands at grant. The filing does not state a total dollar value.

Key Details

• Transaction date: 2026-02-12; Form 4 filed: 2026-02-17 (timely).
• Reported amount: 156,240 derivative shares (stock option award).
• Price shown on Form 4: $0.00 (represents award reported as derivative; exercise price not specified in the summary provided).
• Shares owned after transaction: not disclosed in the provided filing details.
• Footnotes:
  • F1: This is an annual option grant under TuHURA’s 2024 Equity Incentive Plan. One‑third of these options become exercisable on the first, second, and third anniversaries of Feb 12, 2026 (i.e., typical three‑year vesting).
  • F2: The filing also references a prior annual option grant from Jan 2, 2025 with a similar one‑third annual vesting schedule.
• Filing timeliness: Filed within the required window (no late filing flag).

Context

• This was an option award (derivative grant), not an open‑market purchase or sale. Such grants are routine for directors and are typically subject to vesting and exercise requirements; they do not by themselves indicate buying or selling pressure. There is no indication the options were exercised or that any shares were sold immediately.